Related Experiment Videos
Stenotrophomonas maltophilia endocarditis
Nancy F Crum1, Gregory C Utz, Mark R Wallace
1Department of Internal Medicine, Infectious Diseases Division, Naval Medical Center San Diego, San Diego CA 92134, USA. nfcrum@nmcsd.med.navy.mil
Scandinavian Journal of Infectious Diseases
|February 18, 2003
Summary
Stenotrophomonas maltophilia endocarditis is rare but serious, particularly in immunocompromised patients. Early treatment with trimethoprim-sulfamethoxazole and device removal is crucial for better outcomes.
Area of Science:
- Infectious Diseases
- Microbiology
- Cardiology
Background:
- Stenotrophomonas maltophilia is a Gram-negative bacillus increasingly implicated in nosocomial infections.
- Endocarditis caused by S. maltophilia is an uncommon but severe clinical manifestation.
- Immunocompromised patients are particularly vulnerable to severe S. maltophilia infections.
Observation:
- This case report details S. maltophilia endocarditis in a patient with a central venous catheter.
- The clinical presentation and management of this rare condition are described.
- A review of existing literature on Stenotrophomonas endocarditis is presented.
Findings:
- S. maltophilia poses a significant risk for endocarditis, especially in patients with indwelling devices.
- The review highlights the limited but critical data on Stenotrophomonas endocarditis.
- Early diagnosis and intervention are key to managing this infection.
Implications:
- Prompt antibiotic therapy, including trimethoprim-sulfamethoxazole and a second agent, is vital.
- Removal of prosthetic devices, such as central venous catheters, is recommended.
- Aggressive management strategies are necessary due to the high morbidity and mortality associated with S. maltophilia endocarditis.